2020
DOI: 10.3389/fped.2020.00130
|View full text |Cite
|
Sign up to set email alerts
|

Late Administration of Surfactant May Increase the Risk of Patent Ductus Arteriosus

Abstract: Introduction: Early rescue surfactant is the most effective way of administering surfactant but many infants still receive surfactant later. Our aim was to explore the association between timing of surfactant administration and the development of patent ductus arteriosus and other neonatal morbidities. Materials and method: This retrospective study analyzed 819 preterm infants under 30 weeks of gestational age and under 1,500 g. Results: Five hundred and ninety three infants received surfactant during the stud… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0
3

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(14 citation statements)
references
References 16 publications
1
10
0
3
Order By: Relevance
“…Surfactant administration was performed in a lower number of subjects in ≤30 w no-hsPDA group vs. ≤30 w hsPDA (p < 0.05). Such a result seems in agreement with some recent literature results (22,25,26), especially sustaining the association between late surfactant administration (after 2 h of life) and hsPDA, due to the rapid reduction in pulmonary pressure that favors blood flow through PDA (left-to-right shunt), lung hyperflow and ductal persistence (29). Further studies are needed to clarify whether surfactant administration could increase the risk of hsPDA or PDA could have more possibilities to evolve in hsPDA in those preterm neonates with a higher early respiratory impairment at birth, lung hypoxia and alveolar damage, evidenced by an increased need for surfactant and a more severe RDS.…”
Section: Clinical Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Surfactant administration was performed in a lower number of subjects in ≤30 w no-hsPDA group vs. ≤30 w hsPDA (p < 0.05). Such a result seems in agreement with some recent literature results (22,25,26), especially sustaining the association between late surfactant administration (after 2 h of life) and hsPDA, due to the rapid reduction in pulmonary pressure that favors blood flow through PDA (left-to-right shunt), lung hyperflow and ductal persistence (29). Further studies are needed to clarify whether surfactant administration could increase the risk of hsPDA or PDA could have more possibilities to evolve in hsPDA in those preterm neonates with a higher early respiratory impairment at birth, lung hypoxia and alveolar damage, evidenced by an increased need for surfactant and a more severe RDS.…”
Section: Clinical Discussionsupporting
confidence: 92%
“…Several predisposing factors have been associated to PDA condition, sometimes with contrasting results, such as genetic factors (19)(20)(21), maternal pregnancy induced hypertension (PIH) (22), chorioamnionitis (23,24), maternal antepartum hemorrhage, respiratory distress syndrome (RDS), lower birth weight (BW), Apgar score and GA, female gender (22,25), dopamine administration and eccessive intravenous fluid administration (26), neonatal sepsis (27,28), need for surfactant (22,25,26,29), maternal and neonatal drug assumption (2,(30)(31)(32)(33)(34)(35)(36)(37)(38), platelet number, function and other platelet-related parameters (4,5,(39)(40)(41)(42)(43)(44)(45)(46)(47).…”
Section: Introductionmentioning
confidence: 99%
“…It also decreases the risk of pneumothorax, pulmonary interstitial emphysema, neonatal mortality and chronic lung disease in comparison to later rescue surfactant [9]. Additionally, late surfactant administration may also increase the risk of patent ductus arteriosus [10]. An increasing risk of bacterial catheter contamination as shown here adds another argument why early identification of infants requiring exogenous surfactant is important.…”
Section: Discussionmentioning
confidence: 72%
“…Hastalara ait anne yaşı, annede preeklampsi, gestasyonel diyabet, antenatal steroid, gebelik haftası (GH), doğum ağırlığı (DA), doğum şekli (sezaryen/normal vajinal yol), Apgar skorları (1. ve 5. dakika), cinsiyeti, mekanik ventilasyon, non invaziv solunum destek ve oksijen destek süresi, erken neonatal sepsis (ENS, ≤72 saat), geç neonatal sepsis (GNS, >72saat) (7), RDS (8), intraventiküler kanama (İVK, evre ≥3) (9), hemodinamik anlamlı olup tedavi gerektiren patent duktus arteriozus (PDA) (10), tedavi gerektiren prematüre retinopatisi (ROP) (11), orta/ciddi BPD (12), kanıtlanmış ya da ciddi nekrotizan enterokolit (NEK; >2 evre) (13) varlığı, tam enteral beslenmeye geçiş zamanı, YDYBÜ yatış süresi ve mortalite verileri kayıt edildi. Prematüre bebeğin Fenton eğrilerine göre doğum ağırlığı gebelik haftasına göre 10 persentilin altında ise SGA, 10-90 persentil arasında olması durumunda AGA olarak tanımlandı (14).…”
Section: Demografik Ve Klinik öZelliklerunclassified